arimoclomol has been researched along with 4-hydroxy-2-nonenal in 1 studies
| Studies (arimoclomol) | Trials (arimoclomol) | Recent Studies (post-2010) (arimoclomol) | Studies (4-hydroxy-2-nonenal) | Trials (4-hydroxy-2-nonenal) | Recent Studies (post-2010) (4-hydroxy-2-nonenal) |
|---|---|---|---|---|---|
| 34 | 4 | 22 | 3,034 | 26 | 1,103 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JB; Hu, R; Li, X; Sun, H; Yang, HJ | 1 |
1 other study(ies) available for arimoclomol and 4-hydroxy-2-nonenal
| Article | Year |
|---|---|
4-HNE induces proinflammatory cytokines of human retinal pigment epithelial cells by promoting extracellular efflux of HSP70.
Topics: Aldehydes; beta-Cyclodextrins; Blotting, Western; Cells, Cultured; Cysteine Proteinase Inhibitors; Cytokines; Dose-Response Relationship, Drug; HSP70 Heat-Shock Proteins; Humans; Hydroxylamines; Retinal Pigment Epithelium; Transfection | 2019 |